郝浩;张海荣;李文强;孔立;

• 1:山东中医药大学附属医院
• 2:内蒙古自治区中医医院

摘要(Abstract)：

新型冠状病毒肺炎属中医湿热疫范畴。孔立教授查阅古今文献，总结多次抗疫临床经验，认为新冠肺炎的基本病机为湿热，治疗当辨病与辨证相结合，以达原饮为主方治疗，同时应三焦同治、因地制宜、顾护阴津，兼健脾醒胃、行气通滞。

关键词(KeyWords)： 新型冠状病毒肺炎;温疫;湿热;达原饮;孔立;名医经验

Abstract:

Keywords:

基金项目(Foundation): 第七批全国老中医药专家（孔立）学术经验继承工作项目;; 山东省名中医药专家（孔立）项目

作者(Authors): 郝浩;张海荣;李文强;孔立;

参考文献(References)：

• [1] Lombardi Y,Azoyan L,Szychowiak P,et al. External validation of prognostic scores for COVID-19:a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals[J]. Intersive Care Med,2021,47(12):1426-1439.
• [2] Hammond J,Leister-Tebbe H,Gardner A,et al. Oral nirmatrelvir for high-risk,nonhospitalized adults with COVID-19[J]. N Engl J Med,2022,386(15):1397-1408.
• [3] Wang M,Cao R,Zhang L,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus(2019-nCoV)in vitro[J]. Cell Res,2020,30(3):269-271.
• [4] Groneberg DA,Poutanen SM,Low DE,et al. Treatment and vaccines for severe acute respiratory syndrome[J]. Lancet Infect Dis,2005,5(3):147-55.
• [5] Rochwerg B,Agarwal A,Siemieniuk RA,et al. A living WHO guideline on drugs for covid-19[J]. BMJ,2020,370:m3379.
• [6] Recovery Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19(RECOVERY):a randomised,controlled,open-label,platform trial[J]. Lancet,2020,396(10259):1345-1352.
• [7] Recovery Collaborative Group,Horby P,Lim WS,et al. Dexamethasone in hospitalized patients with Covid-19[J]. N Engl J Med,2021,384(8):693-704.
• [8] Janiaud P,Axfors C,Schmitt AM,et al. Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19:A systematic review and Meta-analysis[J].JAMA,2021,325(12):1185-1195.
• [9] ACTIV-3/TICO LY-CoV555 Study Group,Lundgren JD,Grund B,et al. A neutralizing monoclonal antibody for hospitalized patients with Covid-19[J]. N Engl J Med,2021,384(10):905-914.
• [10] Fontana LM,Villamagna AH,Sikka MK,et al. Understanding viral shedding of severe acute respiratory coronavirus virus 2(SARS-CoV-2):Review of current literature[J]. Infect Control Hosp Epidemiol,2021,42(6):659-668.
• [11] CarfìA,Bernabei R,Landi F,et al. Persistent Symptoms in Patients After Acute COVID-19[J]. JAMA,2020,324(6):603-605.
• [12] Halpin SJ,McIvor C,Whyatt G,et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection:A cross-sectional evaluation[J]. J Med Virol,2020,93(2):1013-1022.
• [13] Puelles VG,Lütgehetmann M,Lindenmeyer MT,et al. Multiorgan and renal tropism of SARS-CoV-2[J]. N Engl J Med,2020,383(6):590-592.
• [14] Wichmann D,Sperhake JP,Lütgehetmann M,et al. Autopsy findings and venous thromboembolism in patients with COVID-19:A prospective cohort study[J]. Ann Intern Med,2020,173(4):268-277.
• [15] Solomon IH,Normandin E,Bhattacharyya S,et al. Neuropathological features of Covid-19[J]. N Engl J Med,2020,383(10):989-992.
• [16] Lindner D,Fitzek A,Br?uninger H,et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19autopsy cases[J]. JAMA Cardiol,2020,5(11):1281-1285.
• [17]彭喆，刘明悦，伍啟华，等.从因地制宜探讨不同地区新型冠状病毒肺炎的证治规律[J].山东中医杂志，2021,40(11):1179-1184.
• [18]渠源，王国玉，贾新华.基于“因地制宜”探讨新型冠状病毒肺炎处方用药规律[J].山东中医杂志，2020,39(11):1141-1146.